Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$8.3M
3 rounds on record
Latest round
$8.3M
Venture round · Jan 2024 · 2 yr ago
Team
51-200
employees, estimated range
Backers
1
Cottonwood Technology Fund
The money's age
Long since its last round
32 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jan 2024 $8.3M — SEC Form D
Debt Financing Aug 2021 $3.1M — SEC Form D
Debt Financing Aug 2021 $3.1M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity CircularGenomics, Inc. its site
Founders and leadersfrom filings, registers and the company's site
Alexander HafezExecutive Officer, DirectorSEC Form D
Nikolaos MelliosDirectorSEC Form D
Stephen McKernanExecutive OfficerSEC Form D
Paul SargeantExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
ゲノム ( DNA )、エピゲノム、トランスクリプトーム ( RNA )を独自の技術で解析し、研究開発の効率・精度を格段に向上させます。次世代シーケンス( NGS )/ エピジェネティクス 研究の 実験デザイン から 情報 解析、論文化、事業化までオーダーメイドで支援します。.
Phenomix SciencesVenture round $2.5M · 9 mo ago • Founded 2017 • 11-50 employees
Phenomix Sciences uses AI for precision obesity medicine integrating genetic, clinical, and biomarker data. Deliver the right intervention…
ChromaCode# Life Science/Healthcare# North AmericaVenture round $3.8M · 19 mo ago • Founded 2012 • 201-500 employees
ChromaCode is a leading provider of HDPCR™ multiplexing technology for genomic solutions. Our breakthrough platform enables labs…
Rev GenomicsVenture round $1.5M · 7 yr ago • Founded 2016
A Biotechnology Company Creating Better Plant Medicine Through Data Science, Molecular Genetics and Advanced Tissue Culture. Rev Genomics…
Humane Genomics develops cancer therapies by engineering cancer-killing RNA viruses using a synthetic biology platform.
OGTFounded 2024 • 201-500 employees • 7 roles
Interrogate key biomarkers with our hybridisation-based FISH, NGS and array products for haematology, solid tumour, cytogenetics and rare…

Overview

Advancing precision neurology through brain-derived circular RNA, blood-based biomarkers, and molecular intelligence for neuroscience research.

People

Alexander Hafez
Executive Officer, Director
Nikolaos Mellios
Director
Stephen McKernan
Executive Officer
Paul Sargeant
Executive Officer, Director
Kosmas Karadimitriou
Director
Cathy Petti
Director
Waneta Tuttle
Director
Joseph Cook III
Director
Blivin David
Director
Fortunado Rocca
Director
David Blivin
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Albuquerque United States
HQ
San Diego United States
HQ
Help Advance the Future of Brain Health
10935 Alexandria Way, Suite 201, San Diego, CA 92121
company site

Financials

Total raised
$14.6M
Latest round
Venture - Series Unknown
Funding rounds
3
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $8.3M Details
Debt Financing 2021 $3.1M Details
Debt Financing 2021 $3.1M Details